1. JAAD Case Rep. 2017 Nov 6;3(6):532-533. doi: 10.1016/j.jdcr.2017.06.027. 
eCollection 2017 Nov.

Successful use of dabrafenib after the occurrence of drug rash with eosinophilia 
and systemic symptoms (DRESS) induced by vemurafenib.

Pinard C(1), Mignard C(1), Samain A(1), Duval-Modeste AB(1), Joly P(1).

Author information:
(1)Dermatology Department, Institute for Research and Innovation in Biomedicine, 
Rouen University Hospital, University of Normandie, Rouen, France.

DOI: 10.1016/j.jdcr.2017.06.027
PMCID: PMC5728437
PMID: 29296640